Inimex Pharmaceuticals
Burnaby
About Inimex Pharmaceuticals
Inimex Pharmaceuticals, Inc. is a clinical stage company focused on the development and commercialization of Innate Defense Regulators (IDRs), novel first in class drugs that selectively trigger the body's innate defenses without causing inflammation.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $28.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2008)
- Website: inimexpharma.com
- Phone: +1 604-225-2251
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/inimex-pharmaceuticals-3564420 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.